Evidence map›Paper›PMID 40533516›Full record

ArticleNPJ digital medicine2025

Generalist medical foundation model improves prostate cancer segmentation from multimodal MRI images.

Yuhan Zhang, Xiao Ma, Mingchao Li, Kun Huang, Jie Zhu, Miao Wang, Xi Wang, Menglin Wu, Pheng-Ann Heng

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuhan ZhangSchool of Biomedical Engineering, Shenzhen University, Shenzhen, China.
Xiao MaDepartment of Computer Science and Engineering, Nanjing University of Science and Technology, Nanjing, China.
Mingchao LiAcademy of Arts and Design, Tsinghua University, Beijing, China.
Kun HuangDepartment of Computer Science and Engineering, Nanjing University of Science and Technology, Nanjing, China.
Jie ZhuSenior Department of Urology, The Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Miao WangDepartment of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xi WangDepartment of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, China. xiwang@cse.cuhk.edu.hk.
Menglin WuCarbon Medical Device Ltd., Shenzhen, China. wumenglin@njtech.edu.cn.
Pheng-Ann HengDepartment of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong, China. pheng@cse.cuhk.edu.hk.

Funding

Hong Kong Innovation and Technology Fund GHP/060/21GDNational Natural Science Foundation of China 62402275National Natural Science Foundation of China 62402458Research Grants Council of the Hong Kong Special Administrative Region, China AoE/E-601/24-NResearch Grants Council of the Hong Kong Special Administrative Region, China T45-401/22-N
6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its severity, and design appropriate treatments. This paper presents PCaSAM, a fully automated PCa segmentation model that allows us to input multi-modal MRI images into the foundation model to improve performance significantly. We collected multi-center datasets to conduct a comprehensive evaluation. The results showed that PCaSAM outperforms the generalist medical foundation model and the other representative segmentation models, with the average DSC of 0.721 and 0.706 in the internal and external datasets, respectively. Furthermore, with the assistance of segmentation, the PI-RADS scoring of PCa lesions was improved significantly, leading to a substantial increase in average AUC by 8.3-8.9% on two external datasets. Besides, PCaSAM achieved superior efficiency, making it highly suitable for real-world deployment scenarios.

Identifiers

PMID40533516
PMCPMC12177055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.